Definium Therapeutics Ratios (2019-2026) | DFTX

Ratios Dec2019 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Efficiency
Assets Average (Quarter)
156.62M141.76M157.59M175.45M162.76M148.81M141.82M133.05M200.04M271.84M293.96M310.96M288.74M270.21M251.00M338.51M420.70M
Equity Average (Quarter)
176.11M167.95M157.97M144.23M130.65M139.05M152.25M140.63M118.16M100.98M87.06M137.10M199.05M232.12M251.82M232.13M204.10M158.00M231.46M305.59M
Invested Capital (Quarter)
171.63M164.27M151.66M136.81M124.50M153.59M150.92M130.34M105.97M95.98M78.13M196.06M202.05M262.19M241.45M222.81M185.40M130.60M332.33M278.85M
Leverage & Solvency
Interest Coverage Ratio (Quarter)
-274.50-379.01-423.84-34.21-51.16-52.48-34.10-49.48-53.42-17.49-35.85-37.00-49.35
Debt to Equity (Quarter)
0.150.180.070.120.090.090.100.220.310.120.15
Debt Ratio (Quarter)
0.100.110.050.090.080.070.080.160.170.090.10
Equity Ratio (Quarter)
0.920.920.930.850.890.840.750.680.630.710.750.820.800.810.700.550.760.69
Times Interest Earned (Quarter)
-274.50-379.01-423.84-34.21-51.16-52.48-34.10-49.48-53.42-17.49-35.85-37.00-49.35
Valuation
Enterprise Value (Quarter)
-105.74M-140.60M-131.70M-129.41M-116.89M-115.30M-99.70M-249.10M-242.40M-295.28M-271.50M-209.99M-182.99M-209.06M-409.06M-368.10M
Return Ratios
Return on Capital Employed (Quarter)
-16.73%2.87%3.10%-42.10%-49.54%-71.19%-77.32%-93.12%-70.65%-39.34%-35.93%-38.19%-44.09%-56.11%-81.47%-61.19%-56.94%
Return on Invested Capital (Quarter)
0.00%0.00%
Return on Assets (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%0.00%0.00%
Return on Equity (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%